Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aleglitazar in type 2 diabetes with recent ACS
CTR20130843Phase 3Suspended
- Sponsor
- Roche
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aleglitazar in type 2 diabetes mellitus (T2DM), acute coronary syndrome (ACS), sponsored by Roche. Started Nov 2013; status: suspended.
02
Drugs
aleglitazar
03
Conditions
type 2 diabetes mellitus (T2DM)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on CTR20130843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130843.